Article ID: 27015
Background Reliable estimation of allergic disease prevalence requires validated survey instruments. This study compared prevalence estimates derived from the well-established American Thoracic Society Division of Lung Diseases (ATS-DLD; asthma) and UK Working Party (UKWP; atopic dermatitis) questionnaires with those obtained using the more recently developed Designated Allergic Disease Medical Hospitals (DADMHs) questionnaire to assess agreement within the same population.
Methods:A randomized, crossover internet survey was administered to adults and children. Participants were randomly assigned to two groups to evaluate potential sequencing effects, completing the ATS-DLD or UKWP and DADMHs questionnaires in alternating order. Prevalence estimates and agreement between instruments were compared.
Results:Among 4,726 adults, the DADMHs questionnaire yielded higher prevalence of current (18.7 % vs 11.3 %) and lifetime asthma (29.2 % vs 16.2 %) and a higher remission prevalence (10.5 % vs 5.0 %) than the ATS-DLD. Among 5,019 children, it showed lower current asthma prevalence (16.4% vs 21.8%) but similar lifetime prevalence (25.2 % vs 24.9 %) and a higher remission prevalence (8.7% vs 3.1%). The UKWP questionnaire indicated consistently higher atopic dermatitis prevalence among adults (27.9 % vs 16.7 %) and children (36.1 % vs 18.5 %). Agreement between questionnaires was moderate to substantial for current and lifetime asthma, lower for remission, and moderate for current atopic dermatitis.
Conclusions:The DADMHs questionnaire demonstrated acceptable agreement with established international instruments, supporting its validity for nationwide allergy surveillance in Japan. Refinement of disease-specific definitions may further improve consistency and comparability in long-term monitoring.